ES2582871T3 - Composición terapéutica aromatizada basada en arcilla - Google Patents

Composición terapéutica aromatizada basada en arcilla Download PDF

Info

Publication number
ES2582871T3
ES2582871T3 ES13002485.4T ES13002485T ES2582871T3 ES 2582871 T3 ES2582871 T3 ES 2582871T3 ES 13002485 T ES13002485 T ES 13002485T ES 2582871 T3 ES2582871 T3 ES 2582871T3
Authority
ES
Spain
Prior art keywords
clay
therapeutic composition
composition based
aroma
sweeteners
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES13002485.4T
Other languages
English (en)
Inventor
Jérôme BARRA
Denis Le Hazif
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Firmenich SA
Ipsen Pharma SAS
Original Assignee
Firmenich SA
Ipsen Pharma SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Firmenich SA, Ipsen Pharma SAS filed Critical Firmenich SA
Application granted granted Critical
Publication of ES2582871T3 publication Critical patent/ES2582871T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/12—Magnesium silicate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fats And Perfumes (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Confectionery (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Composición terapéutica aromatizada que contiene arcilla como ingrediente activo y otros aditivos escogidos entre agentes colorantes, edulcorantes, lubricantes y adyuvantes de flujo, caracterizada porque - la arcilla es una esmectita dioctaédrica; y - el aroma está encapsulado.

Description

imagen1
imagen2
imagen3
imagen4

Claims (1)

  1. imagen1
    imagen2
ES13002485.4T 2007-08-13 2008-08-12 Composición terapéutica aromatizada basada en arcilla Active ES2582871T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07291005A EP2025332A1 (fr) 2007-08-13 2007-08-13 Composition thérapeutique aromatisée à base d'argile
EP07291005 2007-08-13

Publications (1)

Publication Number Publication Date
ES2582871T3 true ES2582871T3 (es) 2016-09-15

Family

ID=39052728

Family Applications (2)

Application Number Title Priority Date Filing Date
ES08843692T Active ES2421379T3 (es) 2007-08-13 2008-08-12 Composición terapéutica aromatizada a base de arcilla
ES13002485.4T Active ES2582871T3 (es) 2007-08-13 2008-08-12 Composición terapéutica aromatizada basada en arcilla

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES08843692T Active ES2421379T3 (es) 2007-08-13 2008-08-12 Composición terapéutica aromatizada a base de arcilla

Country Status (27)

Country Link
US (2) US20100159013A1 (es)
EP (3) EP2025332A1 (es)
JP (2) JP5670189B2 (es)
KR (2) KR101503957B1 (es)
CN (2) CN101778622A (es)
AR (2) AR067929A1 (es)
BR (1) BRPI0814979A2 (es)
CA (1) CA2696062C (es)
CL (1) CL2008002366A1 (es)
DK (1) DK2194968T3 (es)
EA (1) EA017118B1 (es)
ES (2) ES2421379T3 (es)
GE (1) GEP20125539B (es)
HK (2) HK1143956A1 (es)
HU (1) HUE029713T2 (es)
MA (1) MA31678B1 (es)
ME (1) ME00975B (es)
MX (1) MX2010001533A (es)
NO (1) NO20100114L (es)
PE (1) PE20090939A1 (es)
PL (2) PL2194968T3 (es)
PT (2) PT2194968E (es)
SA (1) SA08290496B1 (es)
TN (1) TN2010000058A1 (es)
TW (2) TWI519303B (es)
UA (1) UA97408C2 (es)
WO (1) WO2009056703A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2025332A1 (fr) * 2007-08-13 2009-02-18 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) Composition thérapeutique aromatisée à base d'argile
FR2952814B1 (fr) * 2009-11-23 2013-07-19 Ephyla Sas Composition comprenant un complexe de phyllosilicates organiquement modifies generer des emulsions huile dans eau eventuellement a froid
EP2663281B1 (en) 2011-01-12 2016-08-10 Sooft Italia Spa Corneal delivery of cross-linking agents by iontophoresis for the treatment of keratoconus and related ophthalmic compositions
ITUA20162277A1 (it) * 2016-04-04 2017-10-04 Chemists Res Srl Composizione comprendente diosmectite
CN105902625A (zh) * 2016-05-26 2016-08-31 朱胜利 一种小儿止泻药的服用方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4635285A (en) * 1984-07-16 1986-02-10 Sunkist Growers, Inc. Solid essential oil flavor composition and method of manufacture
US4707367A (en) 1984-07-16 1987-11-17 Sunkist Growers, Inc. Solid essential oil flavor composition
JPH064530B2 (ja) * 1985-02-23 1994-01-19 日本化薬株式会社 親水性基剤
US5288497A (en) * 1985-05-01 1994-02-22 The University Of Utah Compositions of oral dissolvable medicaments
JPH08509018A (ja) * 1993-04-16 1996-09-24 マコーミック アンド カンパニー，インク． カプセル化組成物
FR2770778B1 (fr) * 1997-11-12 2000-05-26 Investigations Therapeutiques Composition pour le traitement des gastro-enterites aigues, procede de fabrication de cette composition et solution de traitement obtenue a partir de cette composition
KR20030050958A (ko) * 2001-12-20 2003-06-25 송우영 디옥타헤드랄 스멕타이트를 유효성분으로 함유하는 항균성외용조성물
US8334007B2 (en) * 2003-03-19 2012-12-18 Firmenich Sa Continuous process for the incorporation of a flavor or fragrance ingredient or composition into a carbohydrate matrix
CN100340235C (zh) * 2004-05-21 2007-10-03 山东绿叶制药有限公司 蒙脱石分散片及其制备工艺
EP1627573A1 (en) * 2004-08-20 2006-02-22 Firmenich Sa A process for the incorporation of a flavor or fragrance ingredient or composition into a carbohydrate matrix
JP2006083071A (ja) * 2004-09-14 2006-03-30 Takasago Internatl Corp 香粧品用固形製剤
WO2007051427A1 (fr) * 2005-11-04 2007-05-10 Zhejiang Hailisheng Pharmaceutical Limited Co. Montmorillonite modifiee, son procede de preparation et ses utilisations
FR2901360A1 (fr) 2006-05-16 2007-11-23 Horiba Abx Sas Soc Par Actions Dispositif de conditionnement pour analyse biologique
EP2025332A1 (fr) * 2007-08-13 2009-02-18 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) Composition thérapeutique aromatisée à base d'argile

Also Published As

Publication number Publication date
CA2696062A1 (fr) 2009-05-07
EP2710998B1 (fr) 2016-04-20
EP2194968A1 (fr) 2010-06-16
HK1143956A1 (en) 2011-01-21
EP2710998A1 (fr) 2014-03-26
TW201509424A (zh) 2015-03-16
SA08290496B1 (ar) 2012-11-03
TW200914034A (en) 2009-04-01
TWI511734B (zh) 2015-12-11
EA017118B1 (ru) 2012-09-28
GEP20125539B (en) 2012-05-25
CA2696062C (fr) 2017-09-05
US20100159013A1 (en) 2010-06-24
CL2008002366A1 (es) 2009-05-29
US9056055B2 (en) 2015-06-16
JP2014208715A (ja) 2014-11-06
AR067929A1 (es) 2009-10-28
WO2009056703A8 (fr) 2010-03-04
EP2025332A1 (fr) 2009-02-18
BRPI0814979A2 (pt) 2015-02-03
US20140377354A1 (en) 2014-12-25
CN104173371A (zh) 2014-12-03
NO20100114L (no) 2010-03-10
TWI519303B (zh) 2016-02-01
KR20100055460A (ko) 2010-05-26
KR20140133617A (ko) 2014-11-19
MA31678B1 (fr) 2010-09-01
PT2710998T (pt) 2016-07-28
AR114148A2 (es) 2020-07-29
TN2010000058A1 (fr) 2011-09-26
CN101778622A (zh) 2010-07-14
ES2421379T3 (es) 2013-09-02
EP2194968B1 (fr) 2013-06-19
JP2010535852A (ja) 2010-11-25
EA201070257A1 (ru) 2010-06-30
DK2194968T3 (da) 2013-09-02
PE20090939A1 (es) 2009-07-27
PL2710998T3 (pl) 2016-11-30
HK1196271A1 (zh) 2014-12-12
WO2009056703A1 (fr) 2009-05-07
ME00975B (me) 2012-06-20
KR101503957B1 (ko) 2015-03-18
PL2194968T3 (pl) 2013-10-31
UA97408C2 (ru) 2012-02-10
JP5670189B2 (ja) 2015-02-18
HUE029713T2 (en) 2017-03-28
PT2194968E (pt) 2013-07-25
MX2010001533A (es) 2010-03-15

Similar Documents

Publication Publication Date Title
ES2487496T3 (es) Agente para aliviar el síndrome metabólico
ES2581331T3 (es) Inhibidor de la progresión de una enfermedad atribuida a una acumulación anormal de grasa hepática
ES2582871T3 (es) Composición terapéutica aromatizada basada en arcilla
CO6341541A2 (es) Composiciones para el cuidado oral que comprenden capsulas
ATE460082T1 (de) Formulierungen, die mitkroverkapselte etherische öle enthalten
ES2526555T3 (es) Composición fungicida y método para controlar enfermedades de plantas
GT200600520A (es) Agentes antibacterianos
ES2662320T3 (es) Sistema de matriz autoadhesiva que comprende un copolímero de bloques de estireno
ES2564172T3 (es) Utilización de una composición cosmética para el cuidado de las pieles grasas
AR044131A1 (es) Peliculas consumibles oralmente de disolucion rapida que contienen un almidon modificado para la mejora de la resistencia al calor y a la humedad
CL2008000897A1 (es) Sal de arginina y uno o mas ácidos conjugados; composición de cuidado oral que comprende dicha sal; uso para reducir o inhibir la formacion de caries, desmineralizacion de los dientes; reducir la hipersensibilidad de los dientes, reducir o inhibir la gingivitos entre otras.
AR053099A1 (es) Una composicion de detergente
AR059113A1 (es) Composicion para administracion topica
BRPI0620229A8 (pt) formulação
GT200200065A (es) Composicion parenteral reconstituible
AR072685A1 (es) Composicion topica para el tratamiento de queratosis actinica
AR039936A1 (es) Formulacion farmaceutica de liberacion modificada
NO20071613L (no) Forbindelser for myokardial perfusjons-billeddannelse
CY1109507T1 (el) Φαρμακευτικη συνθεση η οποια περιλαμβανει ενα ελαστομερες οργανοπολυσιλοξανιο και μια διαλυτοποιημενη δραστικη ουσια
MX2009003912A (es) Metodos y composiciones usando compuestos inmunomoduladores para el tratamiento y manejo de enfermedades bacterianas por espiroquetas y otras bacterias intracelulares obligadas.
CR9839A (es) Composicion farmaceutica fotoestable que contiene brivudina para el tratamiento de la queratitis herpetica
CL2007003451A1 (es) Composicion farmaceutica solida oral que comprende un principio activo y polivinilpirrolidona (pvp) entre 1,0-25%, cpaa entre 0,5-10%, el principio activo consiste en una sal hidrosoluble de metal alcalino, de metal alcalino-terreo, una sal de mezcla
UY30065A1 (es) Composiciones farmacéuticas para la erradicación de helicobacter pylori
ES2619837T3 (es) Composición líquida estable de sulfato de condroitina y glucosamina
ES2535528T3 (es) Composición para el tratamiento externo de cadáveres